◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

东诚药业

东诚药业
Loading...
Key Metrics
Market Cap
10.7B ($1.5B)
P/E Ratio
N/A
P/B Ratio
N/A
Revenue
2.9B
Net Income
141.0M
Gross Margin
N/A
Op. Margin
7.7%
Net Margin
4.9%
ROE
2.6%
ROA
1.6%
D/E
0.61
Dividend Yield
N/A
EPS
0.22
Current Ratio
1.46
Price History
Company Info
IndustryC27医药制造业
Market SegmentSME
CurrencyCNY
Fiscal Year2024
Business Overview

Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas. It offers heparin, chondroitin sulphate sodium and calcium, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C. The company also provides nadroparin calcium, hydrocortisone sodium succinate, chorionic gonadotrophin, and menotropins for injection, as well as ambroxol hydrochloride disp...

Peers
工商银行
601398
2.7T
P/E: 7.6
建设银行
601939
2.5T
P/E: 7.2
农业银行
601288
2.4T
P/E: 8.7
中国海油
600938
2.0T
P/E: 16.2
宁德时代
300750
1.9T
P/E: 25.6
贵州茅台
600519
1.8T
P/E: 20.1
中国银行
601988
1.8T
P/E: 7.3
中国人寿
601628
1.2T
P/E: 6.9
Financial Statements
Loading financials...
Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 东诚药业

Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas. It offers heparin, chondroitin sulphate sodium and calcium, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C. The company also provides nadroparin calcium, hydrocortisone sodium succinate, chorionic gonadotrophin, and menotropins for injection, as well as ambroxol hydrochloride dispersible tablets, jinjunling capsule, metformin hydrochloride and glibenclamide tablets, clemastine fumarate tablets, and wind dispelling itch relieving granule. In addition, it offers Technetium Methylene Diphosphonate Injection; Technetium Tc labeled tracers; 2-[18F]FDG that helps to detect the activity of tumor cells; sodium iodide oral solution; iodine seed use to treat internal radiation of various malignant tumors; Urea capsule; and jiabaolin glucosamine chondroitin sulfate capsule. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.


Ticker002675
ExchangeSZSE
Sector证监会行业分类
IndustryC27医药制造业
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...